Nanoscale Metal-Organic Frameworks Generate Reactive Oxygen Species for Cancer Therapy

Overview

Journal ACS Cent Sci

Specialty Chemistry

Date 2020 Jul 2

PMID 32607433

Citations 32

Authors

Kaiyuan Ni

Guangxu Lan

Wenbin Lin

Affiliations

Soon will be listed here.

Abstract

In the past 15 years, enormous progress has been made in cancer nanotechnology, and a several nanoparticles have entered clinical testing for cancer treatment. Among these nanoparticles are nanoscale metal-organic frameworks (nMOFs), a class of organic-inorganic hybrid nanomaterials constructed from metal binding sites and bridging ligands, which have attracted significant attention for their ability to integrate porosity, crystallinity, compositional and structural tunability, multifunctionality, and biocompatibility into a singular nanomaterial for cancer therapies. This Outlook article summarizes the progress on the design of nMOFs as nanosensitizers for photodynamic therapy (PDT), radiotherapy (RT), radiotherapy-radiodynamic therapy (RT-RDT), and chemodynamic therapy (CDT) via nMOF-mediated reactive oxygen species (ROS) generated under external energy stimuli or in the presence of endogenous chemical triggers. Inflammatory responses induced by nMOF-mediated ROS generation activate tumor microenvironments to potentiate cancer immunotherapy, extending the local treatment effects of nMOF-based ROS therapy to distant tumors via abscopal effects. Future research directions in nMOF-mediated ROS therapies and the prospect of clinical applications of nMOFs as cancer therapeutics are also discussed.

Citing Articles

Trends of mapping knowledge structure and themes of cancer sonodynamic therapy: a text-mining study.

Wu H, Cheng K, Sun Z, Lu Y, Guo Q, Li C Quant Imaging Med Surg. 2024; 14(12):8734-8757.

PMID: 39698701 PMC: 11651988. DOI: 10.21037/qims-24-128.

Catalytically Active Ti-Based Nanomaterials for Hydroxyl Radical Mediated Clinical X-Ray Enhancement.

Gerken L, Beckers C, Brugger B, Kissling V, Gogos A, Wee S Adv Sci (Weinh). 2024; 11(47):e2406198.

PMID: 39501581 PMC: 11653640. DOI: 10.1002/advs.202406198.

Recent developments in the bio-mediated synthesis of CoFeO nanoparticles using plant extracts for environmental and biomedical applications.

Tran G, Nguyen L, Nguyen T, Nguyen D, Tran T Nanoscale Adv. 2024; .

PMID: 39364297 PMC: 11446309. DOI: 10.1039/d4na00604f.

Treating Deep-Seated Tumors with Radiodynamic Therapy: Progress and Perspectives.

Zhu S, Lin S, Han R Pharmaceutics. 2024; 16(9).

PMID: 39339173 PMC: 11435246. DOI: 10.3390/pharmaceutics16091135.

Strategies for the development of metalloimmunotherapies.

Sun X, Zhou X, Shi X, Abed O, An X, Lei Y Nat Biomed Eng. 2024; 8(9):1073-1091.

PMID: 38914800 PMC: 11410547. DOI: 10.1038/s41551-024-01221-7.

References

Lu K, He C, Lin W . A Chlorin-Based Nanoscale Metal-Organic Framework for Photodynamic Therapy of Colon Cancers. J Am Chem Soc. 2015; 137(24):7600-3. PMC: 4691355. DOI: 10.1021/jacs.5b04069. View

Tang Z, Liu Y, He M, Bu W . Chemodynamic Therapy: Tumour Microenvironment-Mediated Fenton and Fenton-like Reactions. Angew Chem Int Ed Engl. 2018; 58(4):946-956. DOI: 10.1002/anie.201805664. View

Tamames-Tabar C, Cunha D, Imbuluzqueta E, Ragon F, Serre C, Blanco-Prieto M . Cytotoxicity of nanoscaled metal-organic frameworks. J Mater Chem B. 2020; 2(3):262-271. DOI: 10.1039/c3tb20832j. View

Lan G, Ni K, Veroneau S, Feng X, Nash G, Luo T . Titanium-Based Nanoscale Metal-Organic Framework for Type I Photodynamic Therapy. J Am Chem Soc. 2019; 141(10):4204-4208. DOI: 10.1021/jacs.8b13804. View

Ni K, Aung T, Li S, Fatuzzo N, Liang X, Lin W . Nanoscale Metal-Organic Framework Mediates Radical Therapy to Enhance Cancer Immunotherapy. Chem. 2019; 5(7):1892-1913. PMC: 6681452. DOI: 10.1016/j.chempr.2019.05.013. View

Li Y, Di Z, Gao J, Cheng P, Di C, Zhang G . Heterodimers Made of Upconversion Nanoparticles and Metal-Organic Frameworks. J Am Chem Soc. 2017; 139(39):13804-13810. DOI: 10.1021/jacs.7b07302. View

Rieter W, Taylor K, An H, Lin W, Lin W . Nanoscale metal-organic frameworks as potential multimodal contrast enhancing agents. J Am Chem Soc. 2006; 128(28):9024-5. PMC: 2556368. DOI: 10.1021/ja0627444. View

Luo T, Ni K, Culbert A, Lan G, Li Z, Jiang X . Nanoscale Metal-Organic Frameworks Stabilize Bacteriochlorins for Type I and Type II Photodynamic Therapy. J Am Chem Soc. 2020; 142(16):7334-7339. DOI: 10.1021/jacs.0c02129. View

Park J, Jiang Q, Feng D, Mao L, Zhou H . Size-Controlled Synthesis of Porphyrinic Metal-Organic Framework and Functionalization for Targeted Photodynamic Therapy. J Am Chem Soc. 2016; 138(10):3518-25. DOI: 10.1021/jacs.6b00007. View

10.

Furukawa H, Cordova K, OKeeffe M, Yaghi O . The chemistry and applications of metal-organic frameworks. Science. 2013; 341(6149):1230444. DOI: 10.1126/science.1230444. View

11.

Lu K, He C, Lin W . Nanoscale metal-organic framework for highly effective photodynamic therapy of resistant head and neck cancer. J Am Chem Soc. 2014; 136(48):16712-5. PMC: 4277757. DOI: 10.1021/ja508679h. View

12.

Jain R, Stylianopoulos T . Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol. 2010; 7(11):653-64. PMC: 3065247. DOI: 10.1038/nrclinonc.2010.139. View

13.

Ni K, Luo T, Lan G, Culbert A, Song Y, Wu T . A Nanoscale Metal-Organic Framework to Mediate Photodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Enhance Antigen Presentation and Cancer Immunotherapy. Angew Chem Int Ed Engl. 2019; 59(3):1108-1112. PMC: 8253508. DOI: 10.1002/anie.201911429. View

14.

Lu K, He C, Guo N, Chan C, Ni K, Lan G . Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapy. Nat Biomed Eng. 2019; 2(8):600-610. DOI: 10.1038/s41551-018-0203-4. View

15.

Horike S, Shimomura S, Kitagawa S . Soft porous crystals. Nat Chem. 2010; 1(9):695-704. DOI: 10.1038/nchem.444. View

16.

Shao S, Rajendiran V, Lovell J . Metalloporphyrin Nanoparticles: Coordinating Diverse Theranostic Functions. Coord Chem Rev. 2018; 379:99-120. PMC: 6294123. DOI: 10.1016/j.ccr.2017.09.002. View

17.

Liu D, Lu K, Poon C, Lin W . Metal-organic frameworks as sensory materials and imaging agents. Inorg Chem. 2013; 53(4):1916-24. PMC: 4108452. DOI: 10.1021/ic402194c. View

18.

He C, Lu K, Liu D, Lin W . Nanoscale metal-organic frameworks for the co-delivery of cisplatin and pooled siRNAs to enhance therapeutic efficacy in drug-resistant ovarian cancer cells. J Am Chem Soc. 2014; 136(14):5181-4. PMC: 4210117. DOI: 10.1021/ja4098862. View

19.

Dolmans D, Fukumura D, Jain R . Photodynamic therapy for cancer. Nat Rev Cancer. 2003; 3(5):380-7. DOI: 10.1038/nrc1071. View

20.

Lu K, Aung T, Guo N, Weichselbaum R, Lin W . Nanoscale Metal-Organic Frameworks for Therapeutic, Imaging, and Sensing Applications. Adv Mater. 2018; 30(37):e1707634. PMC: 6586248. DOI: 10.1002/adma.201707634. View